Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)

Inclusion Criteria

• •Signed informed consent for this trial prior to any trial specific assessment.
• •Male and female subjects with SBS-IF and CIC, receiving parenteral support (PS), secondary to surgical resection of the small intestine with \< 200 cm from duodenojejunal flexure.
• •Subject must require parenteral support (PS) at least 2 days per week and be considered stable.
• •No restorative surgery intended to change PS requirements in the trial period.
• •Age ≥ 18 years at screening.